# Pandemic Hazard Model

## Risk Layer

Compartmental SEIR model (Susceptible-Exposed-Infected-Recovered): dS/dt = -βSI/N, dE/dt = βSI/N - σE, dI/dt = σE - γI, dR/dt = γI. Parameters: β (transmission rate) = 0.5-1.5 contacts/day, σ (incubation rate) = 1/5.5 days, γ (recovery rate) = 1/10 days. R0 (basic reproduction number) estimated 1.2-3.5 depending on variant. CDC FluSight model probabilistic ensemble. Risk categories: Green (R<1.0), Yellow (1.0-1.5), Orange (1.5-2.5), Red (>2.5). Spatial disaggregation: county-level transmission.

## Ongoing Hazard Model

CDC surveillance data (RESP-NET, FluNet, Wastewater Monitoring) ingested daily via CDC DCIPHER API. Wastewater SARS-CoV-2 RNA quantification from 2,600+ treatment plants (NWSS: National Wastewater Surveillance System). Ct values tracked; Ct<30 indicates high prevalence. Variant detection via genomic sequencing (1-2% of positive specimens sequenced). Hospital admission data from HHS Protect system (real-time bed occupancy, ICU capacity). Vaccination coverage from CDC Vaccine Safety Datalink. Mobility data from Google/Apple (movement patterns inform contact rate β adjustment).

## Spread/Evolution

Transmission rate modulation: β = β_base × (1 - vaccine_coverage × effectiveness) × (1 + mobility_factor). Variant-specific adjustments: Delta (1.5x transmissibility), Omicron (2.0x), BA.2 (3.5x vs. ancestral). Incubation shortens: Omicron 3-4 days vs. 5.5 ancestral. Population immunity calculation: immunity_fraction = vaccination_coverage + recovered_fraction. Breakthrough infection probability: 5-15% for 2-dose, 2-5% for 3+ dose. Mutation rate: new variants emerge 3-6 month intervals under high transmission.

## Lethality

Case fatality rate (CFR): 0.5-2.0% depending on variant and age. Age stratification: <18 years (0.01%), 18-49 (0.1-0.3%), 50-64 (1.0-2.0%), >65 (5-10%). Comorbidity multiplier: diabetes (3.8x), obesity (1.9x), chronic respiratory (2.2x). Vaccination impact: 85-95% CFR reduction post-dose 3. Hospital mortality: 20-40% of admitted. ICU mortality: 40-60%. Long COVID incidence: 10-30% of recovered (months-long disability). Excess mortality: cumulative deaths minus baseline forecast (pandemic period: 600k+ excess deaths US).

## Safe Zones

Home isolation during high transmission (R>2.0): 95% risk reduction. Outdoor spaces: <1% transmission risk if physical distance >2m. Vaccination-only venues (proof-of-status enforcement): 85% risk reduction vs. unvaccinated. Air-filtered spaces (HEPA + UV, >12 ACH): 90% risk reduction. Healthcare settings with proper PPE (N95 respirators): 98% reduction. Natural immunity areas (post-infection, >90 days): temporary protection 70-85% vs. reinfection. Booster-vaccinated population groups: 60-80% protection vs. infection, >95% protection vs. severe disease.

## Evacuation

High-incidence phases: recommend work-from-home, school closures, remote learning. Evacuation trigger: hospital ICU capacity >85%. Hospital overflow protocol: alternate care sites activated (field hospitals, hotel conversions). Intensive care expansion: 2-4 week ramp-up time. PPE rationing: crisis standards of care implemented. Healthcare worker reassignment: 15-20% workforce reallocation from elective care. Vaccine distribution priority: healthcare workers > elderly > essential workers > general population. Mental health support activation: counseling/telehealth expansion.

## Vulnerability

Unvaccinated population: 8-12x higher hospitalization risk. Elderly (>75): 50-60x higher mortality vs. young. Immunocompromised (3-5% of population): 10-100x risk depending on condition. Healthcare workers: 1.5x occupational exposure vs. general public. Essential workers (food, transport, manufacturing): 60% higher infection rate. Incarcerated populations: 5-7x higher transmission due to density. Homeless: 3-4x vulnerability (chronic disease, inadequate isolation space). Racial/ethnic minorities: 2.5-3.5x higher mortality (comorbidity, access disparities).

## Secondary Effects

Healthcare system collapse: non-COVID mortality increases 25-40% (delayed surgeries, preventive care interruption). Mental health crisis: anxiety/depression increase 50-80%, suicide risk elevation. Economic disruption: supply chain delays, labor shortages. School closures: learning loss (7-10 months equivalent per year closure), mental health impact. Vaccine hesitancy proliferation: misinformation reduces uptake 15-25%. Long COVID disability: 2-3% of workforce productivity loss. Variant escape: vaccine effectiveness wanes (re-vaccination needs 6-12 month intervals).

## Operational Protocols

R>1.5 sustained 2 weeks: activate state health emergency. CDC coordinates vaccine/PPE distribution. Governor declares emergency (executive orders). Schools assess closure timing. Healthcare surge capacity planning: activate alternate sites. Public health messaging campaign (vaccine efficacy, masking, ventilation). Supply chain coordination: medical supplies, oxygen, antivirals. Crisis standards of care protocols briefed. Isolation/quarantine guidelines issued. Testing expansion: rapid test distribution, PCR capacity surge. Hospitalization capacity monitoring (HHS Protect daily). Variant surveillance enhancement (genomic sequencing targets).

## Caching/Offline

Pre-cache CDC epidemiological curves (14-day lookback, GeoJSON). Store SEIR model parameters/coefficients locally (JSON, 1MB). Cache vaccination coverage data by county (updated weekly). Offline mode provides 30-day transmission forecast (based on last sync). Store hospital bed capacity reference data (ICU, ventilator counts). Cache variant prevalence percentages (regional, updated weekly). Store public health guidance documents (masking, testing, vaccination). Background tiles include healthcare facility locations (hospitals, clinics). Timestamp all data; refresh daily 1800 UTC.

## Comms/UI

Alert (R=2.1): "Pandemic transmission HIGH in Metro Area. Cases increase 40% weekly. Vaccination recommended. Hospital capacity: 78% ICU beds. Testing sites: map below. Work-from-home guidance active." Push frequency: 3x daily if R>2.0, daily if 1.0-2.0, weekly if <1.0. SMS: "COVID risk HIGH. Vaccine available at CVS. Test positive? Get Paxlovid now." Web: real-time county transmission map (red/yellow/green), hospital capacity gauge, variant breakdown, vaccination coverage by demographic, new variant alerts. Timeline: 14-day cases/deaths trend. Voice: CDC hotline (1-800-CDC-INFO) integration.

## Sensor Input

Primary: CDC surveillance (RESP-NET, FluSight Model). Secondary: Wastewater genomics (NWSS, 2600+ plants). Tertiary: HHS Protect hospital data (real-time bed tracking). Quaternary: CDC Vaccine Safety Datalink (vaccination coverage, demographics). Quinary: Mobility data (Google/Apple anonymized). Genomic sequencing (1-2% positive samples sequenced). Variant detection (monkeypox cross-check). Mobile: symptom reports (Kinsa fever thermometer network). PCR test result reports (healthcare provider integration). Traveler screening data (airport symptom surveys). Long COVID patient registry (CDC CoLiver program).

## SEIR Extended Model Dynamics

Age-stratified compartments: 5 age bands (0-17, 18-49, 50-64, 65-79, 80+) with distinct transmission/severity parameters. Maternal immunity (newborns): protection wanes 4-6 months post-maternal antibody. Vaccination compartments: unvaccinated, partial (1-dose), full (2-dose), booster (3+ dose). Waning immunity curve: VE(t) = VE_0 × exp(-ω×t) where ω = 0.001-0.005/day (5-10 month half-life). Reinfection risk: previous infection provides 70-85% protection, wanes faster for novel variants. Asymptomatic rate: 35-50% of infected remain presymptomatic (5-day window). Incubation period distribution: gamma-distributed mean 5.5 days, 90% range 2-10 days. Infectious period: 10 days total (5 days pre/post-peak shedding).

## Hospital Surge Forecasting

ICU admission rate: 2-5% of symptomatic cases (age-dependent, 15%+ for age 65+). Hospital length of stay: 7-10 days average, 20+ days for ICU patients. Ventilator requirement: 50-80% of ICU patients, 10-14 day duration. Staffing surge: 20-30% additional nurse/physician hours required at 80% capacity. PPE consumption: mask 5/day, gown 3/day, N95 2/day per patient. Bed expansion timeline: 3-7 days for physical setup (additional wards, temporary facilities). Surge capacity limits: typical hospital baseline 400-600 beds, surge to 1000-1500 (including field hospitals). Regional coordination: 3-5 hospital networks coordinate resources (ICU patient transfers, staff sharing, supply distribution).

## Vaccination Distribution Optimization

Allocation priority: healthcare workers (phase 1a), elderly >65 (1b), essential workers (1c), general population (2). Supply chain: manufacturing 100M doses/month capacity, distribution center network 5-10 regional hubs. Cold chain requirements: mRNA vaccines -70°C, adenoviral +4°C (logistical complexity increases 3x). Vaccination site capacity: drive-through (200-300/day), clinic (500-1000/day), mass events (2000-5000/day). Coverage target: 70% reduces transmission 60-70%, 85% reduces 80%+. Hesitancy modeling: 10-25% population resistance (misinformation, fear). Equity assessment: racial/ethnic disparity targets (minimize >10% coverage gap). Booster scheduling: 6-month intervals for optimal antibody response (waning simulations).

## Variant Tracking Architecture

Genomic surveillance: sequencing 1-2% of PCR-positive specimens (500-1000 sequences/week per 1M population). Lineage nomenclature: Pango lineages tracked (B.1.617, BA.1, BA.2, etc.). Growth advantage estimation: new variant prevalence increase 5-10% weekly indicates 1.5-2.0x transmissibility. Phenotype forecasting: laboratory assays estimate vaccine escape (20-40% VE reduction per major variant). Rt estimation: instantaneous reproduction number from case curves (renewal process framework). Risk assessment: fatality, severity, hospitalizer, immune evasion scored per variant. Geographic spread: seeding events detected via phylogeographic analysis (travel patterns inferred). Pre-print/publication lag: 2-4 week delay from sequencing to peer review (interim guidance via CDC emergency updates).

## Long-COVID Disability Modeling

Symptom prevalence: fatigue (58%), cognitive dysfunction (22%), dyspnea (21%), cardiac (8%), loss of taste (17%). Work disability: 25-40% of patients unable to work full-time 6+ months post-infection. Disability duration: 10-15% remain symptomatic >1 year. Healthcare costs: $2,000-5,000 per patient per year (outpatient specialty visits, tests). Comorbidity interaction: diabetes/obesity increase long-COVID risk 2-3x. Age factor: 45-55 age group highest prevalence (childbearing + working age). Mental health comorbidity: 30-40% develop depression/anxiety (5-year persistence). Rehabilitation programs: pulmonary/cardiac rehab reduces disability 20-30%, cognitive rehab modest (5-10%) benefit. Worksite accommodation requirements: flexible scheduling, remote work, ergonomic support.
